1-20 of 134
Hongmei Jing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A prospective, multicenter, real-world study of glofitamab in Chinese patients with relapsed or refractory large B-cell lymphoma

Free
Li Wang, Jiayin He, Zhihua Yao, Hongmei Jing, Songfu Jiang, Xia Zhao, Wenrong Huang, Hongbin Lu, Zhao Peiqi, Lihong Liu, Jianzhen Shen, Wei Li Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7252.
https://doi.org/10.1182/blood-2025-7252
Published: 2025
Journal Articles

Effectiveness and safety of axicabtagene ciloleucel (Axi-cel) in Chinese patients with relapsed/refractory non-Hodgkin lymphoma: Age subgroup analysis of real-world study

Free
Zi-Xun Yan, Wenbin Qian, Ying Lu, Keshu Zhou, Dongmei Ji, Yuhua Li, Dehui Zou, Lanfang Li, Lei Zhang, Ping Li, Hongmei Jing, Chunyan Ji, Ting Niu, Fei Li, Xiaojian Zhu, Jinghua Zhao, Yu Hu, Depei Wu, Wei Li Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7230.
https://doi.org/10.1182/blood-2025-7230
Published: 2025
Journal Articles

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Free
Yuhong Ren, Jia Liu, Zhijuan Lin, Lihong Shou, Hui Zeng, Dong Wu, Zhiyong Zeng, Fengping Zhou, Li Bao, Hongmei Jing, Songfu Jiang, Haisheng Liu, Jianzhen Shen, Wenjuan Yu, Hui Zhou, Jingyan Xu, Yan Zhang, Ting Wang, Honghui Huang, Bing Xu, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7229.
https://doi.org/10.1182/blood-2025-7229
Published: 2025
Journal Articles

Safety and effectiveness of brentuximab vedotin in Chinese adult patients with classical Hodgkin's lymphoma: Results from a multicenter, prospective, observational, real-world study

Free
Wei Li, Chuanxu Liu, Wenyang Huang, Ou Bai, Lihong Liu, Zengjun Li, Wei Xu, Wei Zhang, Liping Su, Kaiyang Ding, Luqun Wang, Guohui Cui, Hongmei Jing, Jianli Wang, Ziheng Guo, Weili Zhao, Huilai Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 7135.
https://doi.org/10.1182/blood-2025-7135
Published: 2025
Journal Articles

Phase I study of a CD19-directed CAR-T cell therapy for Relapsed/refractory mantle cell lymphomas(MCL)

Free
Ping Yang, Jinjie Gao, Lan Luo, Weilong Zhang, Jing Wang, Hongmei Jing
Journal: Blood
Blood (2025) 146 (Supplement 1): 7125.
https://doi.org/10.1182/blood-2025-7125
Published: 2025
Journal Articles

Short-term follow-up results of ultra-low-dose radiotherapy for indolent B-cell lymphoma

Free
Min Li, Ran Peng, Ping Yang, Fang Bao, Jijun Wang, Qihui Li, Hongmei Jing, Hao Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 7113.
https://doi.org/10.1182/blood-2025-7113
Published: 2025
Journal Articles

Genomic characterization uncovers molecular subtypes in Mantle Cell Lymphoma

Free
Changjian Yan, Ping Yang, Jie Chen, Chaoling Wu, Xiaoyu Hao, Jing Wang, Mingxia Zhu, Yan Liu, Weilong Zhang, Hongmei Jing
Journal: Blood
Blood (2025) 146 (Supplement 1): 3590.
https://doi.org/10.1182/blood-2025-3590
Published: 2025
Journal Articles

Heterogeneous TP53 mutation subtypes define prognostic classification in Mantle Cell Lymphoma

Free
Shuozi Liu, Ping Yang, Shaowei Zhou, Weilong Zhang, Jing Wang, Lingli Wang, Chunyuan Li, Yingtong Chen, Wenxin Qi, Hongmei Jing
Journal: Blood
Blood (2025) 146 (Supplement 1): 3589.
https://doi.org/10.1182/blood-2025-3589
Published: 2025
Journal Articles

Efficacy and safety of rocbrutinib, a highly selective 4th-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory Mantle Cell Lymphoma (R/R MCL): Updated results from the phase 1 study

Free
Yuqin Song, Qingqing Cai, Keshu Zhou, Zhengming Jin, Ming Jiang, Xiuhua Sun, Lei Zhang, Haiyan Yang, Lanfang Li, Kaiyang Ding, Junyuan Qi, MIN Zhou, Hongmei Jing, Wei Yang, Hui Zhou, Jun Ma, Zhigang Peng, Wei Xu, Yuankai Shi, Guohui Cui, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Jun Zhu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3587.
https://doi.org/10.1182/blood-2025-3587
Published: 2025
Journal Articles

Efficacy and safety of rocbrutinib, the fourth generation bruton's tyrosine kinase inhibitor, in patients with BTK inhibitor pre-treated relapsed or refractory Mantle Cell Lymphoma: Results from a Phase II rock-1 trial

Free
Yuqin Song, Qingqing Cai, Xiaoqiong Tang, Keshu Zhou, Lihong Liu, Zhigang Peng, Xiaojing Yan, Kaiyang Ding, Jianzhen Shen, Huijing Wu, Jie Cui, Hui Zhou, Jianqiu Wu, Hongmei Jing, Ming Jiang, Xiuhua Sun, Yu Yang, Kang Yu, Wei Yang, Zhifeng Li, Zhengming Jin, Shuhua Yi, Fei Li, Guowu Wu, Xiaolei Wei, Gaoxiang Wang, Yudan Wu, Ningjing Lin, Fenlai Tan, Yue Shen, Yejiang Lou, Xiang Xiao, Jun Zhu
Journal: Blood
Blood (2025) 146 (Supplement 1): 886.
https://doi.org/10.1182/blood-2025-886
Published: 2025
Journal Articles

Phase 1/2 studies of DZD8586 in CLL/SLL patients after COVALENT and non-COVALENT BTK inhibitors and BTK degraders – extended follow-up report

Free
Keshu Zhou, Tingyu Wang, Wei Yang, Jian-Qing Mi, Sujun Gao, Huayuan Zhu, Xutao Guo, Kaiyang Ding, Ying Xiang, Huili Cai, Guohui Cui, Yun Zhuang, Hongmei Jing, Liping Su, Rui Huang, Lihua Qiu, Mark Geyer, Wuhan Hui, Geoffrey Chong, Meifang Zheng, Yi Wang, Ying Li, Ke Fang, Chan Cheah, Jianyong Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 3889.
https://doi.org/10.1182/blood-2025-3889
Published: 2025
Journal Articles

Ferritin change and predictors of anemia response in ruxolitinib-intolerant myelofibrosis patients treated with gecacitinib

Free
Yi Zhang, Hu Zhou, Zhijian Xiao, Minghui Duan, Sujun Gao, Guangsheng He, Hongmei Jing, Junmin Li, Liangming Ma, Huanling Zhu, Chunkang Chang, Xin Du, Mei Hong, Xin Li, Qingchi Liu, Wei WANG, Na Xu, Haiping Yang, Jie Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 2029.
https://doi.org/10.1182/blood-2025-2029
Published: 2025
Journal Articles

Efficacy and safety of gecacitinib in thrombocytopenic myelofibrosis patients

Free
Yi Zhang, Hu Zhou, Junling Zhuang, Zhongxing Jiang, Dengshu Wu, Qingchi Liu, Huanling Zhu, Qike Zhang, Xin Du, Sujun Gao, Qian Jiang, Wei Li, Linhua Yang, Yuqing Chen, Aili He, Jinwen Huang, Yan Li, Xiuli Wang, Guangsheng He, Hongmei Jing, Zhijian Xiao, Minghui Duan, Mei Hong, Fei Li, Yarong Li, Liangming Ma, Jishi Wang, Wei WANG, Wen Wu, Na Xu, Feng Zhang, Jie Jin
Journal: Blood
Blood (2025) 146 (Supplement 1): 2028.
https://doi.org/10.1182/blood-2025-2028
Published: 2025
Journal Articles

Tucidinostat plus R-CHOP in untreated MYC/BCL2 double-expressor diffuse large B-cell lymphoma：topline efficacy and safety results from the randomized phase 3 DEB study

Free
Wei Li Zhao, Jun Zhu, Pengpeng Xu, Yuqin Song, Jianzhen Shen, Qingqing Cai, Hui Zhou, Liling Zhang, Ying Xiang, Xiuhua Sun, Wei Yang, Zhihua Yao, Hongmei Jing, Shujuan Wen, Jie Jin, Hongwei Xue, Hong Cen, Kaiyang Ding, Zhengming Jin, Lihong Liu, Xiaojing Xing, Lanfang Li, Ming Hou, Lin LIU, Mingzhi Zhang, Wenyu Li, Ou Bai, Ru Feng, Zunmin Zhu, Huijing Wu, Liping Su, Li Gao, Fei Li, Wenrong Huang, Peng Liu, Xiaojing Yan, Ying Zhao, Hang Su, Xielan Zhao, Rong FU, Hong Liu, Wenyu Shi
Journal: Blood
Blood (2025) 146 (Supplement 1): 475.
https://doi.org/10.1182/blood-2025-475
Published: 2025
Journal Articles

Analysis of factors associated with clinical response in glofitamab's treatment of relapsed or refractory (R/R) large B-cell lymphoma

Free
Lan Luo, Yaxin Zheng, Ping Yang, Xu Zhang, Fei Dong, Jijun Wang, Hongmei Jing
Journal: Blood
Blood (2025) 146 (Supplement 1): 7262.
https://doi.org/10.1182/blood-2025-7262
Published: 2025
Journal Articles

Efficacy and safety of zanubrutinib combined with reduced-dose bendamustine and Rituximab for eldly Mantle Cell Lymphoma: A retrospective analysis

Free
Ping Yang, Shuozi Liu, Chuanyuan Li, Lan Luo, Weilong Zhang, Jing Wang, Hongmei Jing
Journal: Blood
Blood (2025) 146 (Supplement 1): 7097.
https://doi.org/10.1182/blood-2025-7097
Published: 2025
Journal Articles

Renal response of selinexor,  bortezomib, pomalidomide, and dexamethasone in newly diagnosed multiple myeloma patients with renal impairment: A phase 2, prospective, multicenter study

Free
Huixing Zhou, Long Chang, Jie Ma, Songying Zhao, Jingnan Sun, Sun Liping, Xiaoqi Qin, Hongmei Jing, Jingrong Wang, He-Bing Zhou, Xiaolei Chen, Hai Zhou, Zhenling Li, Wenrong Huang, Yi Ma, Guohong Su, Jun Luo, Guoxiang Zhang, Biyun Chen, Weiwei Tian, Guang-Yu Ma, Jihao Zhou, Wenming Chen, Hong-Hu Zhu, Jian Li, Wen Gao
Journal: Blood
Blood (2025) 146 (Supplement 1): 5830.
https://doi.org/10.1182/blood-2025-5830
Published: 2025
Journal Articles

Isatuximab (Isa) subcutaneous (SC) via an on-body injector (OBI) vs isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): East asia subgroup results from the randomized, non-inferiority, phase 3 iraklia study

Free
Xuelin Dou, Chunrui Li, Aijun Liao, Yafei Wang, Zhongjun Xia, Jing Liu, Hong Cen, Yan Xu, Fei Li, Tadao Ishida, Yuping Zhong, Satoshi Ito, Togano Tomiteru, Baijun Fang, Chunyan Sun, Hongmei Jing, Masaki Ri, Toshiyuki Kitano, Kazutaka Sunami, Chihiro Shimazaki, Shigeki Ito, Jie Jin, Rong Fu, Takuya Komeno, Kosei Matsue, Shang-Yi Huang, Sikander Ailawadhi, Florence Suzan Teisserenc, Dan Gao, Xu Wang, Yi Li, Gang Liu, Jin Lu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5819.
https://doi.org/10.1182/blood-2025-5819
Published: 2025
Journal Articles

Updated survival outcomes of pomalidomide/bortezomib/dexamethasone in newly diagnosed multiple myeloma with renal impairment: A prospective, open-label, multicenter, phase 2 study

Free
Yuan Jian, Long Chang, Shi Minxia, Ying Sun, Xiao-Xia Chu, Hua Xue, Wenrong Huang, Xuliang Shen, Jie Ma, Guo-Rong Jia, Ya-Qing Feng, Zhen-Fang Xi, Yan-Hong Zhao, Yanping Ma, Jing Xiao, Guang-Yu Ma, Qing-Ming Wang, LI Bao, Yujun Dong, He-Bing Zhou, Chunyan Sun, Guo-Hong Su, Yan Yan, Sai-Yin Qimuge, Liping Su, Jingnan Sun, Weiwei Tian, Xiu Li Sun, Hongmei Jing, Da Gao, Hong-Hu Zhu, Wenming Chen, Jian Li, Wen Gao
Journal: Blood
Blood (2025) 146 (Supplement 1): 5818.
https://doi.org/10.1182/blood-2025-5818
Published: 2025
Journal Articles

Prognostic and therapeutic implications of the immune landscape in Mantle Cell Lymphoma

Free
Changjian Yan, Chaoling Wu, Ping Yang, Xiaoyu Hao, Jie Chen, Jing Wang, Mingxia Zhu, Yan Liu, Hongmei Jing, Weilong Zhang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1821.
https://doi.org/10.1182/blood-2025-1821
Published: 2025